Elpiscience Biopharmaceuticals
PrivateLast Round
Corporate Funding
Dec 28, 2023
Est. Valuation
$600M
Total Funding Raised
$260M
Company Overview
Elpiscience Biopharmaceuticals is a biopharmaceutical company that develops immunotherapies for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elpiscience Biopharmaceuticals Comparables
Compare Elpiscience Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpimAb Biotherapeutics | 89% | |
| ImmuneOnco Biopharmaceuticals | 82% | |
| BioNTech SE | 82% |
Elpiscience Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 28, 2023 | ||||
| Series C | May 13, 2021 | ||||
| Series B | Dec 28, 2019 | ||||
| Series A Extension | Dec 3, 2018 | ||||
| Series A | Aug 30, 2017 |
Elpiscience Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series B, Series C |
| CDH Investments | Series A Extension, Series B, Series C |
| Oriza Holdings | Series B, Series C |
| Hillhouse Investment | Series C, Series A Extension, Series B |
| Ming Bioventures | Series B |
| Cormorant Asset Management | Series C |
| CITIC Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 34% MoM, reaching 2.3K.
- Dec 28, 2023
$37M raised with Astellas Pharma Inc. as an investor.
Elpiscience Biopharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elpiscience Biopharmaceuticals's valuation, stock price, and market status.
Is Elpiscience Biopharmaceuticals a public or private company?
Elpiscience Biopharmaceuticals is a private company.
What is the current stock price of Elpiscience Biopharmaceuticals?
Elpiscience Biopharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Elpiscience Biopharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elpiscience Biopharmaceuticals worth (valuation)?
Elpiscience Biopharmaceuticals's valuation is estimated at $600.0M based on funding round data.
Can I buy Elpiscience Biopharmaceuticals stock?
Elpiscience Biopharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elpiscience Biopharmaceuticals's last funding round?
Elpiscience Biopharmaceuticals's most recent funding round was Corporate Funding on December 28, 2023.
Who are the main investors in Elpiscience Biopharmaceuticals?
Key investors in Elpiscience Biopharmaceuticals include Hillhouse Investment, Lilly Asia Ventures, Hyfinity Investments, Lilly Asia Ventures, Greater Bay Area Homeland.
Will Elpiscience Biopharmaceuticals IPO soon?
No public IPO plans have been announced for Elpiscience Biopharmaceuticals.
How can I track Elpiscience Biopharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Elpiscience Biopharmaceuticals's shares on secondary markets.